The study identifies IGF2BP1 as an m6A reader that regulates Keap1/Nrf2 pathway activity, but the specific molecular mechanism linking m6A binding to pathway modulation remains unexplained. Understanding this mechanism is crucial for developing targeted therapeutic interventions. Gap type: unexplained_observation Source paper: IGF2BP1 exacerbates neuroinflammation and cerebral ischemia/reperfusion injury by regulating neuronal ferroptosis and microglial polarization. (2025, Biochimica et biophysica acta. Molecular basis of disease, PMID:40294852)
Landscape Summary: How does IGF2BP1 mechanistically regulate Keap1/Nrf2 signaling through m6A modifications? is a 0.8 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How does IGF2BP1 mechanistically regulate Keap1/Nrf2 signaling through m6A modifications? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: